T. Tesar

发表

M. Huic, Z. Kaló, W. Goettsch, 2020, Expert review of pharmacoeconomics & outcomes research.

P. Kawalec, A. Inotai, M. Wawruch, 2019, Health Policy and Technology.

J. Skoupá, G. Petrova, P. Kawalec, 2017, Front. Pharmacol..

G. Petrova, P. Kawalec, J. Gulbinovič, 2017, Front. Pharmacol..

S. Mišíková, T. Tesar, Z. Haramiová, 2020, Bratislavske lekarske listy.

A. Olczak-Pieńkowska, H. Blix, R. Strauss, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

V. Praze, Karlova V Praze, T. Tesar, 2011 .

T. Tesar, L. Masarykova, Slávka Porubcová, 2021, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti.

T. Bochenek, Z. Kaló, D. Vitezić, 2017 .

T. Tesar, Z. Haramiová, Z. Koblišková, 2017 .

P. Kawalec, A. Inotai, M. Wawruch, 2020, Frontiers in Public Health.

J. Murín, M. Wawruch, G. Wimmer, 2017, Aging Clinical and Experimental Research.

Ľ. Lehocká, M. Wawruch, T. Tesar, 2017, International Journal of Technology Assessment in Health Care.

N. Maniadakis, J. Espín, Z. Kaló, 2021, Cost Effectiveness and Resource Allocation.

Š. Laššán, T. Tesar, J. Tisoňová, 2023, Frontiers in Pharmacology.

G. Petrova, P. Kawalec, J. Gulbinovič, 2020, Orphanet Journal of Rare Diseases.

T. Tesar, L. Masarykova, Ubica Lehocká, 2020, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti.

L. Garrison, Z. Kaló, Z. Vokó, 2018, Health Policy and Technology.